Jeffrey Chamberlain, Ph.D.

Professor of Neurology, Biochemistry, and Medicine
Research Affiliate, Center on Human Development and Disability
jsc5@uw.edu
206-221-5363
University of Washington
Box 357720
Seattle, WA 98195-7720

Dr. Chamberlain researches the muscular dystrophies, primarily Duchenne muscular dystrophy (DMD), to develop a better understanding of the molecular basis of the pathophysiology of the diseases, and to develop gene and cell therapies to correct and treat them. DMD is the most common form of muscular dystrophy, affecting one in 3,500 newborn males, and is caused by mutations in the dystrophin gene. Chamberlain and his associates are studying the structure and function of the dystrophin gene, as well as developing viral vectors to deliver this or other genes to muscle cells for possible gene therapy.